Publication: Saw palmetto extract induces nuclear heterogeneity in mice
Issued Date
2009-01-01
Resource Type
ISSN
13826689
Other identifier(s)
2-s2.0-57149143563
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Environmental Toxicology and Pharmacology. Vol.27, No.1 (2009), 149-154
Suggested Citation
Wachareeporn Trinachartvanit, Bettina M. Francis, A. Lane Rayburn Saw palmetto extract induces nuclear heterogeneity in mice. Environmental Toxicology and Pharmacology. Vol.27, No.1 (2009), 149-154. doi:10.1016/j.etap.2008.09.006 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/27592
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Saw palmetto extract induces nuclear heterogeneity in mice
Other Contributor(s)
Abstract
Saw palmetto (SW), a phytotherapeutic compound used in the treatment of prostate disease, was examined for potential nuclear effects. SW extract was incorporated into a complete casein-based semisynthetic rodent chow at 0%, 0.1% and 1% SW. SW was fed to mice for 6 weeks, after which the mice received a single i/p injection of either the known genotoxic agent methyl methanesulfonate (MMS) in saline or just saline. Forty-eight hours after injection, blood and bone marrow were collected for flow cytometric analysis. A significant effect of MMS was observed in both male and female mice with respect to: an increase in nuclear heterogeneity in bone marrow cells as measured by the coefficient of variation of the G1 peak in a flow histogram (6.32 versus 4.8 in male mice, 7.0 versus 4.9 in female mice) and an increase in the number of micronucleated blood cells (3.4% versus 0.56% male mice, 3.1% versus 0.6 in female mice) indicating a positive genotoxic response. SW also appears to increase the heterogeneity of bone marrow nuclei in a dose dependent manner (0-5.1%, 0.1-5.5% and 1-5.7% in male mice, 0-5.7%, 0.1-6.0% and 1-6.2% in female mice) without a concomitant increase in blood cell micronuclei. These results indicate that SW is not genotoxic with respect to physical DNA damage and that the changes observed in the bone marrow are due to chromatin conformation modifications in the nuclei of in vivo treated mouse cells. © 2008 Elsevier B.V. All rights reserved.